RankAlpha logo
Back to Rankings

HURA

TuHURA BiosciencesB
Nasdaq / Pharmaceuticals, Biotechnology & Life Sciences
Last Price
At close
2026-07-20
View Chart
+
Peers tracked
11
U.S. public peers
Grade Position
Above peers
vs peer average
HURA vs peer average
75/100
HURA vs. peer average (B vs. D)
Grade spread
A 1 · B 1 · C 3 · D 3 · F 3
Graded peers loaded
Coverage
11 graded
100% of tracked

Peer overview

ACAD is the first available peer comparator.

Small/medium-cap biotech with rare-disease programs and similar liquidity profile; useful operational comparison.

✓Peer source comes from the stored AI memo or peer model
✓Grades and factor rows use RankAlpha API data when available
✓Missing peer scores remain blank instead of being estimated
✓Side-by-side comparison keeps the data contract visible
Top peerACADACADIA
HURA
TuHURA Biosciences
ACAD
ACADIA
Grade
B
A
Momentum
98
75
Value
41
62
Sentiment
45
49
Setup Bias
Net —
-
Market Cap
-
-
Posture
Constructive
Constructive
Open Side-by-Side ComparisonCompare all

Grade position vs ACAD

HURA / ACAD
Grade Position
Above peers
HURA vs. peer average (B vs. D)
75/100
Momentum
98
HURA
Value
41
ACAD
Sentiment
45
ACAD

Rotation landscape

Peers ranked by the order returned from the peer source, with grades from the API.

Rank
Ticker
Company
Grade
Grade score
vs HURA
1
ACAD
ACAD
A
100/100
-1
2
EDIT
EDIT
C
60/100
+1
3
CRSP
CRSP
B
80/100
Even
4
PYXS
Pyxis Oncology Inc Common
D
40/100
+2
5
NGEN
NervGen Pharma Corp Common
F
20/100
+3
ACAD is the first peer returned for this comparison set.